378 related articles for article (PubMed ID: 29666154)
1. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
Mitra P; Weinheimer S; Michalewicz M; Taub ME
Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
[TBL] [Abstract][Full Text] [Related]
2. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
3. Pre-incubation with cyclosporine A potentiates its inhibitory effects on pitavastatin uptake mediated by recombinantly expressed cynomolgus monkey hepatic organic anion transporting polypeptide.
Takahashi T; Ohtsuka T; Uno Y; Utoh M; Yamazaki H; Kume T
Biopharm Drug Dispos; 2016 Nov; 37(8):479-490. PubMed ID: 27603548
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
[TBL] [Abstract][Full Text] [Related]
5. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method.
Chan GH; Houle R; Zhang J; Katwaru R; Li Y; Chu X
Drug Metab Dispos; 2023 Sep; 51(9):1089-1104. PubMed ID: 37137718
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.
Pahwa S; Alam K; Crowe A; Farasyn T; Neuhoff S; Hatley O; Ding K; Yue W
J Pharm Sci; 2017 Aug; 106(8):2123-2135. PubMed ID: 28373111
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
[TBL] [Abstract][Full Text] [Related]
9. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
J Pharmacol Exp Ther; 2004 Oct; 311(1):139-46. PubMed ID: 15159445
[TBL] [Abstract][Full Text] [Related]
10. Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes.
Izumi S; Nozaki Y; Kusuhara H; Hotta K; Mochizuki T; Komori T; Maeda K; Sugiyama Y
Mol Pharm; 2018 Jun; 15(6):2277-2288. PubMed ID: 29746136
[TBL] [Abstract][Full Text] [Related]
11. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Static Model based Prediction of Transporter Substrate Drug-Drug Interactions Utilizing Atorvastatin and Rifampicin.
Mitra P; Kasliwala R; Iboki L; Madari S; Williams Z; Takahashi R; Taub ME
Pharm Res; 2023 Dec; 40(12):3025-3042. PubMed ID: 37821766
[TBL] [Abstract][Full Text] [Related]
13. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
Farasyn T; Pahwa S; Xu C; Yue W
Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
[TBL] [Abstract][Full Text] [Related]
14. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
Zhang Y; Ruggiero M; Hagenbuch B
Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
[TBL] [Abstract][Full Text] [Related]
15. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.
Fujino H; Saito T; Ogawa S; Kojima J
J Pharm Pharmacol; 2005 Oct; 57(10):1305-11. PubMed ID: 16259759
[TBL] [Abstract][Full Text] [Related]
16. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes.
Bi YA; Costales C; Mathialagan S; West M; Eatemadpour S; Lazzaro S; Tylaska L; Scialis R; Zhang H; Umland J; Kimoto E; Tess DA; Feng B; Tremaine LM; Varma MVS; Rodrigues AD
J Pharmacol Exp Ther; 2019 Jul; 370(1):72-83. PubMed ID: 30975793
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
19. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
20. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]